These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32576459)

  • 21. Efficacy of high-dose versus standard-dose influenza vaccine in older adults.
    DiazGranados CA; Dunning AJ; Kimmel M; Kirby D; Treanor J; Collins A; Pollak R; Christoff J; Earl J; Landolfi V; Martin E; Gurunathan S; Nathan R; Greenberg DP; Tornieporth NG; Decker MD; Talbot HK
    N Engl J Med; 2014 Aug; 371(7):635-45. PubMed ID: 25119609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluzone® High-Dose Influenza Vaccine.
    Robertson CA; DiazGranados CA; Decker MD; Chit A; Mercer M; Greenberg DP
    Expert Rev Vaccines; 2016 Dec; 15(12):1495-1505. PubMed ID: 27813430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors.
    Becker DL; Chit A; DiazGranados CA; Maschio M; Yau E; Drummond M
    Hum Vaccin Immunother; 2016 Dec; 12(12):3036-3042. PubMed ID: 27669017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin Use and Risks of Influenza-Related Outcomes Among Older Adults Receiving Standard-Dose or High-Dose Influenza Vaccines Through Medicare During 2010-2015.
    Izurieta HS; Chillarige Y; Kelman JA; Forshee R; Qiang Y; Wernecke M; Ferdinands JM; Lu Y; Wei Y; Xu W; Lu M; Fry A; Pratt D; Shay DK
    Clin Infect Dis; 2018 Jul; 67(3):378-387. PubMed ID: 29438483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surveillance for Guillain-Barré syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiaries.
    Arya DP; Said MA; Izurieta HS; Perez-Vilar S; Zinderman C; Wernecke M; Alexander M; White T; Su IH; Lufkin B; MaCurdy T; Kelman J; Forshee R
    Vaccine; 2019 Oct; 37(43):6543-6549. PubMed ID: 31515146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic evaluation of high-dose inactivated influenza vaccine in adults aged ≥65 years: A systematic literature review.
    Colrat F; Thommes E; Largeron N; Alvarez FP
    Vaccine; 2021 Mar; 39 Suppl 1():A42-A50. PubMed ID: 33518466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial.
    Chit A; Becker DL; DiazGranados CA; Maschio M; Yau E; Drummond M
    Lancet Infect Dis; 2015 Dec; 15(12):1459-66. PubMed ID: 26362172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Age on Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries Aged ≥65 Years.
    Lu Y; Chillarige Y; Izurieta HS; Wei Y; Xu W; Lu M; Sung HM; Lindaas A; Wernecke M; Macurdy T; Kelman J; Forshee RA
    J Infect Dis; 2019 Sep; 220(9):1511-1520. PubMed ID: 31290553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of influenza vaccine in the elderly.
    Nichol KL; Margolis KL; Wouremna J; von Sternberg T
    Gerontology; 1996; 42(5):274-9. PubMed ID: 8940650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011-2012 to 2016-2017.
    Gaglani M; Vasudevan A; Raiyani C; Murthy K; Chen W; Reis M; Belongia EA; McLean HQ; Jackson ML; Jackson LA; Zimmerman RK; Nowalk MP; Monto AS; Martin ET; Chung JR; Spencer S; Fry AM; Flannery B
    Clin Infect Dis; 2021 Apr; 72(7):1147-1157. PubMed ID: 32006430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Annual Burden of Seasonal Influenza in the US Veterans Affairs Population.
    Young-Xu Y; van Aalst R; Russo E; Lee JK; Chit A
    PLoS One; 2017; 12(1):e0169344. PubMed ID: 28046080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative Vaccine Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among Veterans Health Administration Patients.
    Young-Xu Y; Van Aalst R; Mahmud SM; Rothman KJ; Snider JT; Westreich D; Mor V; Gravenstein S; Lee JKH; Thommes EW; Decker MD; Chit A
    J Infect Dis; 2018 May; 217(11):1718-1727. PubMed ID: 29452380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database.
    Mangtani P; Cumberland P; Hodgson CR; Roberts JA; Cutts FT; Hall AJ
    J Infect Dis; 2004 Jul; 190(1):1-10. PubMed ID: 15195237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of clinical outcome and outcome period definitions on estimates of absolute clinical and economic benefits of influenza vaccination in community dwelling elderly persons.
    Nichol KL; Nordin J; Mullooly J
    Vaccine; 2006 Mar; 24(10):1562-8. PubMed ID: 16300868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influenza vaccination, hospitalizations, and costs among members of a Medicare managed care plan.
    Davis JW; Lee E; Taira DA; Chung RS
    Med Care; 2001 Dec; 39(12):1273-80. PubMed ID: 11717569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients.
    Wongsurakiat P; Lertakyamanee J; Maranetra KN; Jongriratanakul S; Sangkaew S
    J Med Assoc Thai; 2003 Jun; 86(6):497-508. PubMed ID: 12924797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis.
    Izurieta HS; Thadani N; Shay DK; Lu Y; Maurer A; Foppa IM; Franks R; Pratt D; Forshee RA; MaCurdy T; Worrall C; Howery AE; Kelman J
    Lancet Infect Dis; 2015 Mar; 15(3):293-300. PubMed ID: 25672568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010-2016.
    Thompson MG; Kwong JC; Regan AK; Katz MA; Drews SJ; Azziz-Baumgartner E; Klein NP; Chung H; Effler PV; Feldman BS; Simmonds K; Wyant BE; Dawood FS; Jackson ML; Fell DB; Levy A; Barda N; Svenson LW; Fink RV; Ball SW; Naleway A;
    Clin Infect Dis; 2019 Apr; 68(9):1444-1453. PubMed ID: 30307490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.
    Nichol KL; Margolis KL; Wuorenma J; Von Sternberg T
    N Engl J Med; 1994 Sep; 331(12):778-84. PubMed ID: 8065407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Future epidemiological and economic impacts of universal influenza vaccines.
    Sah P; Alfaro-Murillo JA; Fitzpatrick MC; Neuzil KM; Meyers LA; Singer BH; Galvani AP
    Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20786-20792. PubMed ID: 31548402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.